Telix Pharmaceuticals TLX Ratios (2023-2026)

NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Telix Pharmaceuticals Quarterly Ratios

Periods 4 quarters
Latest Jun 2026

Telix Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 4 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2023 Dec2024 Dec2025 Jun2026
Efficiency
Inventory AverageInventory Avg. 18.11M31.01M38.05M
Assets AverageAssets Avg. 627.98M1,077.83M1,262.92M
Equity AverageEquity Avg. 234.26M393.48M451.53M
Invested CapitalInvested Cap. 102.91M744.87M820.40M1,004.06M
Leverage & Solvency
Debt Ratio 0.020.380.350.38
Valuation
Price to BookP/B 13.876.118.01
Enterprise Value 4,653.54M2,358.48M3,613.78M
Market Capitalization 5,154.76M2,537.44M3,906.10M

Telix Pharmaceuticals Ratios API

Pull Telix Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TLX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY